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A B S T R A C T
The goal of this study was to compare the possibilities and limitations of direct digital radiography of the chest
(DDR), the use of ultrasound of the chest (US) and single slice computed tomography of the chest (CT) in diagnosing
pleural mesothelioma. The study was conducted during the course of one year, on 80 patients who were successively re-
ferred to a specialized institution, under clinical suspicion of mesothelioma. The method of investigation was the com-
parison of findings, obtained by the reviewed methods of examination, with the pathohistologic results of a biopsy per-
formed on each patient. The findings that were obtained by the enumerated methods were classified according to the
radiologic signs that were found in each individual patient. We evaluated following radiological findings (signs), on
each of the investigated methods: plaques, localized and generalized pleural thickenings, calcifications of the pleura,
pleural effusions, parapneumonic effusions, pleural empyema, (round) atelectasis, pneumothorax, tumor mass or node,
inflammatory infiltrate, elevation of the hemidiaphragm and osteolysis. The results of these were compared with patho-
histologic findings and analyzed by means of standard statistical methods. The highest sensitivity was found for CT
(94.4 %), followed by US (92.6%), and by DDR (90.7%). The highest specificity was obtained with DDR (46.2 %), followed
by CT (35.5%) and US (23.8%). The comparison of these methods showed 90% diagnostic accuracy for DDR in relation to
CT. CT as an individual method best satisfied most of the criteria for diagnosing mesothelioma. No pathognomonic
radiologic sign for mesothelioma was found.
Key words: pleural mesothelioma, malignant mesothelioma, diagnosing mesothelioma, sensitivity of imaging meth-
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Introduction
Malignant mesothelioma is primary tumor of the se-
rous envelop, most common in costal, diaphragmal and
mediastinal pleura1. Mesothelioma can appear in focal or
diffuse form. Focal form is ussualy benign tumor, diffuse
is commonly malignant. Malignant mesothelioma is stron-
gly associated with asbestos exposure, with latency pe-
riod of few to 35 years. The recognition of pleural disease,
particularly mesothelioma leads to the consideration of
variety of processes and involvement of physicians from
many specialities. Diagnostic imaging has key role in de-
tection, diagnosis and treatment of pleural mesotheli-
oma. The rising number of radiologic imaging techniques
and the development of new diagnostic methods presents
a challenge in choosing the most appropriate means for
establishing a definite diagnosis of malignant pleural me-
sothelioma. The methods having a key role in diagnosing
it are: direct digital radiography of the chest (DDR), ul-
trasound of the chest (US) and single-slice or multi-slice
chest computed tomography (CT). In the literature up to
now there has been no unique stance in evaluating these
radiologic diagnostic methods for this disease.
The aim of this study has been to highlight the
strengths and weaknesses of the avaible imaging tech-
niques and provide some guidance for their use. The aim
has therefore been to establish the presence of character-
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istic radiologic signs, in each diagnostic method and com-
pared with histopathological findings. Furthermore, the
goal was to form, for each method separately, a model of
the features, with positive and negative predictors, and
combined models. We wanted to determine, on the basis
of the obtained data, whether a pathognomonic radiolo-
gic sign for the diagnosis of mesothelioma exists, using
the mentioned methods.
By means of calculations of: sensitivity, specificity,
positive and negative predictive values, diagnostic accu-
racy, ratio between the probability for a positive and for a
negative test and the diagnostic probability, to assess the
possibilities and limitations in the application of each
method in the detection of mesothelioma. And certainly,
to compare the diagnostic accuracy of DDR, US and CT.
It was assumed that the obtained results could be a
basis for a proposed algorhythm for examinations in di-
agnosing mesothelioma.
Patients and Methods
In a one year period, on 80 hospitalized patients (65
men and 15 women) with suspected mesothelioma, radio-
logic diagnostic procedures were performed (DDR, US,
CT). The average age of the examinees was 56.8 (24–94)
years. The average age of the men (57.6 years) did not
differ statistically from the average age of the women
(53.6 years).
The criteria for including the patients in this study
required a previous clinical examination by a specialist in
pulmology who had established a clinical suspicion of
pleural disease that requested further radiological elabo-
ration. The leading clinical symptoms were: chest pain,
including referred pain localized to the shoulder, cough,
dyspnea, and weight loos combined with finding of pleu-
ral effusion. Positive anamnesis of asbestos exposure was
found in 43 patients. All patients had digital radiograms
with two views of the thorax, except for partially mobile
or immobile patients who had a supine or sitting frontal
thoracic radiogram. Standard radiograms were followed
by US and CT.
Direct digital radiography of the chest was performed
on a Thoromat Siemens Thorax FD appliance. For ultra-
sonic diagnostics a SAOT ultrasound appliance was used,
and for computed tomography, a spiral CT Shimadzu
SCT 7800 TX.
In patients with pathologic changes in the peripheral
thoracic zone discovered by DDR, ultrasound was applied
using a 3.5MHz convex transducer. For diagnosing pro-
cesses localized within the thoracic wall a linear 7.5 MHz
transducer was used.
CT of the thoracic region was performed in the stan-
dard manner, with 7mm thick slices and 7mm intervals
between them. The findings for each radiologic method
were classified according to the radiologic signs that were
found in each patient.
The pathologic specimens for pathohistologic analysis
were obtained by biopsy with ultrasound guidance (in
the case of superficially located changes) or under fluo-
roscopy monitoring (for changes located at a greater
depth). We evaluated presence of the following radiologi-
cal findings (signs), on each of the investigated methods:
plaques, localized and generalized pleural thickenings,
calcifications of the pleura, pleural effusions, parapneu-
monic effusions, pleural empyema, (round) atelectasis,
pneumothorax, tumor mass or node, inflammatory infil-
trate, elevation of the hemidiaphragm and osteolysis.
These signs are already established as »classic« radiology
findings that can suggest mesotehelioma2.
The findings were observed by two independent radi-
ologist one senior radiologist (20 years of experience) and
another young radiologist (5 years of experience). Every
reading was blinded to the findings of other methods.
Each observer made report with positive or negative ra-
diological signs found on DDR, US and CT (Table 1, 4, 7).
Interobserver variability was 2.4% for DDR findings,
1.6% for CT of the chest and 3.2% for US findings. A
third observer (15 years of experience) then evaluated
the discordant findings.
Statistical analysis was performed using the Stati-
stica for Windows, Release 6 (StatSoft, Inc. Tulsa, OK)
statistical program package. For the description of age,
arithmetic mean, standard deviation and range was used,
and for comparison between genders the Student t-test
was used. For comparison between categorical variables
among the subgroups the c2 was used. Categorical vari-
ables were presented as frequency (%). In order to estab-
lish the link between individual variables that are cate-
gorical and their affiliation with the analyzed subgroups,
a logistic regressive analysis was performed, including
monovariant and multivariant models. Multivariant mo-
dels were obtained on the basis of monovariant connec-
tions between individual variables. In order to compare
the value of particular imaging presentations they were
compared to a standard (pathohistologic analysis), and
for them calculations were made: for sensitivity, specific-
ity, positive (PPV) and negative (NPV) predictive value,
diagnostic accuracy (DA), likelihood ratio (LR) and diag-
nostic odds (DO). For all parameters a 95% interval of re-
liability was calculated. In view of the small contribution
of other diagnoses (other than mesothelioma), it was not
possible to assess the diagnostic value of particular imag-
ing presentations (US, X-ray, CT) or characteristic find-
ings in each of these, in a way that would exclude the
findings being chance results. As statistically significant,
a p<0.05 level of significance was used.
Results
According to pathohistologic results a diagnosis of
malignant mesothelioma was confirmed in 54 (67.5%)
patients (45 men and 9 women), with an average age of
60.4 (39–80) years. The age of men and women did not
differ with statistical significance in the whole group or
in the group with a confirmed malignant mesothelioma
diagnosis (p>0.05). The group of patients with malig-
nant mesothelioma was statistically markedly older than
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the remaining patients with suspected mesothelioma
(60.4±9.9 in relation to 49.4±15.9 years; p=0.0003). Pa-
thohistology confirmed diagnosis of mesothelial variant
of malignant mesothelioma in 38 patients, sarcomatous
in 11 patients and and mixed in 5 patients. Patho-
histology did not confirmed diagnosis of benign mesothe-
lioma in no one of our patients. Positive anamnesis of as-
bestos exposure was found in 43 (79.6%) patients with
confirmed diagnosis of malignant mesothelioma. Among
the patients in whom mesothelioma was excluded, non-
specific inflammatory pleural effusion was most frequent,
in a total of 12 (15%) of patients (7M and 5F). The next
most frequent finding was a primary tumor, in a total of
6 (7.5%) patients (6M, 0F), followed by metastatic tu-
mors in 4 (5%) of patients (3M and 1F). In 2 (2.5%) pa-
tients a tuberculous inflammatory effusion was found.
One patient (1.3%) was diagnosed with inflammatory
changes of pulmonary parenchyma, and another with
malignant effusion (without confirmation of the primary
tumor site).
No significant statistical difference was established
between gender in relation to the prevalence of each par-
ticular enumerated diagnosis (p=0.4394).
Digital radiography findings
According to the results of examinations using the
DDR technique, the most frequent radiologic signs in pa-
tients with mesothelioma were pleural thickening, pla-
que and calcification. In the group of patients with meso-
thelioma, a tumor mass or node (p=0.0146), pneumo-
thorax (p=0.0213), and an inflammatory infiltrate (p=
0.0057) were present significantly more infrequently.
The most significant PPV of 100%, was found for plaque
and calcification, with a NPV of 34.7%, but with low sen-
sitivity of 9.3% and 100% specificity. The lowest PPV of
16.7% was found for inflammatory infiltrate, with a NPV
of 28.4%, 1.9% sensitivity, and 80.8% specificity. No sin-
gle characteristic radiologic sign found on DDR had a sta-
tistically significant higher frequency of appearance in
the group of patients with mesothelioma. The results dis-
playing the presence of characteristic radiologic signs in
DDR findings, depending on the pathohistologic diagno-
sis, are shown in Table 1.
The results in Table 2 indicate the diagnostic value of
characteristic digital radiography findings with a 95% re-
liability interval. Although pleural effusion is present in
96.3% mesothelioma cases, it is also present in 92.3% pa-
tients with other diagnoses. Pleural thickening which is
present in 32.5% patients with mesothelioma is present
also in 23.1% of other patients. A relatively small num-
ber of registered plaques and calcifications limits the di-
agnostic value of these signs. No single sign displays a di-
agnostic value in the positive prediction of mesothelioma.
Regarding negative predictors (tumor mass or node,
pneumothorax or inflammatory infiltrate), all exhibit a
relatively high specificity (69.2%, 80.8%, 80.8%), and a
significant DO (95% CI does not exceed 1).*
On the basis of the characteristics that individual
signs exhibited, models were formed that included posi-
tive predictors (pleural thickening, plaque, calcification),
negative predictors (tumor mass or node, pneumothorax,
and inflammatory infiltrate), and also a model that com-
bines positive and negative predictors for the diagnosis of
mesothelioma, in order to verify their diagnostic value
(Table 3).
The combined model (which includes positive and
negative predictors for the diagnosis of mesothelioma) is
best, with a statistically significant DO (8.4). In spite of
relatively high sensitivity, PPV, NPV and DA, this model
does not diagnose 5 (9.3%) patients with mesothelioma.
It classifies 14 (53.8%) patients with other diagnoses in
the mesothelioma group (Table 3).
US findings
According to the investigation results displayed in Ta-
ble 4, not one characteristic US finding demonstrated a
statistically significant more frequent or more infre-
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TABLE 1
PRESENCE OF A SINGLE RADIOLOGIC SIGN ON DIGITAL RADIOGRAPHY DEPENDING ON THE PATHOHISTOLOGIC DIAGNOSIS
Characteristic finding Total (N=80) Mesothelioma (N=54) Other diagnoses (N=26) p-value*
X-ray - sign, number (%)
Effusion 76 (95.0) 52 (96.3) 24 (92.3) 0.4433
Pleural thickening 25 (31.3) 19 (35.2) 6 (23.1) 0.2738
Plaque 5 (6.3) 5 (9.3) 0 0.1091
Calcification 5 (6.3) 5 (9.3) 0 0.1091
Osteolysis 0 0 0 0.9999
Tumor mass or node 13 (16.3) 5 (9.3) 8 (30.8) 0.0146
Pneumothorax 7 (8.8) 2 (3.7) 5 (19.2) 0.0213
Inflammatory infiltrate 6 (7.5) 1 (1.9) 5 (19.2) 0.0057
Elevation of hemidiaphragm 6 (7.5) 3 (5.6) 3 (11.5) 0.3413
Atelectasis 3 (3.8) 2 (3.7) 1 (3.9) 0.9749
*p-value for difference between diagnoses
quent appearance in the group of patients with mesothe-
lioma. This indicates that a single characteristic US find-
ing pathognomonic for mesothelioma does not exist.
The most significant PPV was found for the presence
of an anechogenic pleural effusion –74.5%, with NPV
44.8%, sensitivity 70.4%, and specificity 50%. Invasion of
the thoracic wall had the lowest PPV of 0%, NPV 26%,
sensitivity 0%, specificity 73.1%. The results for the diag-
nostic values of characteristic ultrasound findings with a
95% interval of reliability are displayed in Table 5.
On the basis of the characteristics that individual
signs exhibited, models of US features, as well as for
DDR, were formed. In spite of relatively high sensitivity,
PPV and NPV, the combined model does not diagnose 4
(7.4%) patients with mesothelioma, and classifies 20
(76.9%) patients with other diagnoses in the mesotheli-
oma group, exposing them to further diagnostic and
therapeutic procedures (Table 6).
CT findings
According to the results (shown in Table 7) the most
significant PPV for CT finding is the presence of plaque
and calcification (PPV=100%, with a NPV of 37.7% and
35.1%), but with low sensitivity (20.4%, and 11.1%) and
specificity 100%. The lowest PPV of 0% was found for
pneumothorax, while it had a NPV of 29%, sensitivity 0%
and specificity 84.6%.
Although pleural thickening and plaque have con-
gruent diagnostic characteristics the independent pres-
ence of one of these signs in a maximum of 77.7% (the
upper limit of 95% CI for pleural thickening) of patients
is not sufficient to allow the independent use of any one
of these signs in diagnosing this disease. Regarding neg-
ative predictors, (tumor mass or node, pneumothorax,
inflammatory infiltrate) all exhibit relatively high spec-
ificity (69.2%, 84.6%, 80.8%), and significant DO (95%
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TABLE 2
DIAGNOSTIC VALUES OF CHARACTERISTIC FINDINGS ON DIGITAL RADIOGRRAPHY WITH 95% INTERVALS OF RELIABILITY
Characteristic
finding
Sensitivity Specificity PPV NPV DA +LR –LR DO
Effusion 96.3%
(87.5–98.9)
7.7%
(2.1–24.1)
68.4%
(57.3–77.8)
50%
(15–85)
67.5%
(56.6–76.8)
1.043
(0.96–1.13)
0.482
(0–164200)
2.167
(0.29–16.3)
Pleural
thickening
35.2%
(23.8–48.5)
76.9%
(58–89)
76%
(56.6–88.5)
36.4%
(24.9–49.6)
48.8%
(38.1–59.5)
1.525
(0.91–2.56)
0.843
(0.77–0.92)
1.81
(0.62–5.27)
Plaque 9.3%
(4–19.9)
100%
(87.1–100)
100%
(56.6–100)
34.7%
(24.9–46)
38.8%
(28.8–49.7)
ND
0.907
(0.87–0.94)
ND
Calcification 9.3%
(4–19.9)
100%
(87.1–100)
100%
(56.6–100)
34.7%
(24.9–46)
38.8%
(28.8–49.7)
ND
0.907
(0.87–0.94)
ND
Tumor mass or
node
9.3%
(4–19.9)
69.2%
(50–83.5)
38.5%
(17.7–64.5)
26.9%
(17.7–38.5)
28.8%
(20–39.5)
0.301
(0.01–17.9)
1.311
(1.2–1.43)
0.230
(0.07–0.79)
Pneumothorax 3.7%
(1.02–12.5)
80.8%
(62.1–91.5)
28.6%
(8.2–64.1)
28.8%
(19.7–40)
28.8%
(20–39.5)
0.193
(0–?)
1.192
(1.12–1.27)
0.162
(0.03–0.9)
Inflammatory
infiltrate
1.9%
(0.3–9.8)
80.8%
(62.1–91.5)
16.7%
(3–56.4)
28.4%
(19.4–39.5)
27.5%
(18.9–38.1)
0.096
(0–?)
1.215
(1.15–1.29)
0.079
(0.01–0.72)
Elevation of
hemidiaphragm
5.6%
(1.9–15.1)
88.5%
(71–96)
50%
(18.8–81.2)
31.1%
(21.7–42.3)
32.5%
(23.2–43.4)
0.482
(0–61640)
1.068
(1.02–1.12)
0.451
(0.08–2.41)
Atelectasis 3.7%
(1–12.5)
96.2%
(81.1–99.3)
66.7%
(20.8–93.9)
32.5%
(23.1–43.5)
33.8%
(24.4–44.6)
0.963
(0–?)
1.001
(0.96–1.04)
0.962
(0.08–11.1)
Legend: ND – non-defined, PPV – positive predictive value, NPV – negative predictive value, DA – diagnostic accuracy, +LR – likeli-
hood ratio for a positive test, –LR – likelihood ratio for a negative test, DO – diagnostic odds
TABLE 3
MODELS OF DDR FEATURES WITH 95% INTERVALS OF RELIABILITY
Model Sensitivity Specificity PPV NPV DA +LR –LR DO
Positive
predictors
42.6%
(30.3–55.8)
76.9%
(58–89)
79.3%
(61.6–90.2)
39.2%
(27–52.9)
53.8%
(42.9–64.3)
1.846
(1.19–2.87)
0.746
(0.68–0.82)
2.473
(0.86–7.14)
Negative
predictors
14.8%
(7.7–26.6)
42.3%
(25.5–61.1)
34.8%
(18.8–55.1)
19.3%
(11.1–31.3)
23.8%
(15.8–34.1)
0.257
(0.06–1.2)
2.013
(1.51–2.68)
0.128
(0.04–0.38)
Combined
model
90.7%
(80.1–96)
46.2%
(28.8–64.5)
77.8%
(66.1–86.3)
70.6%
(46.9–86.7)
76.3%
(65.9–84.2)
1.685
(1.46–1.95)
0.201
(0.11–0.36)
8.4
(2.53–27.9)
Legend: ND – non-defined, P – PV-positive predictive value, NPV – negative predictive value, DA – diagnostic accuracy, +LR – likeli-
hood ratio for a positive test, –LR – likelihood ratio for a negative test, DO – diagnostic odds
CI does not exceed 1). These results are presented in Ta-
ble 8.
The combined model for CT (Table 9), which in-
cludes positive and negative predictors for the diagnosis
of mesothelioma, is the best one with a statistically sig-
nificantly highest DO (10.63). With high sensitivity,
PPV, NPV, and DA that are statistically significantly
higher (no overlap of 95% CI), this model does not diag-
nose only 3 (5.5%) patients with mesothelioma, but due
to low specificity (38.3%) it includes 16 (61.5%) patients
with other diagnoses into the mesothelioma group,
maybe exposing them to unnecessary diagnostic and
therapeutic procedures.
Discussion
Several important characteristics of the methods for
diagnosing mesothelioma that were studied derive from
the results that are presented:
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TABLE 5
DIAGNOSTIC VALUES OF CHARACTERISTIC FINDINGS ON US EXAMINATIONS WITH 95% INTERVALS OF RELIABILITY
Characteristic finding Sensitivity Specificity PPV NPV DA +LR –LR DO
Anechogenic effusion 70.4%
(57.2–80.1)
50%
(32.1–67.9)
74.5%
(61.1–84.5)
44.8%
(28.4–62.5)
63.8%
(52.8–73.4)
1.407
(1.18–1.67)
0.593
(0.45–0.78)
2.375
(0.90–6.24)
Complex non-loculated
effusion
9.3%
(4.0–19.9)
88.5%
(71.0–96)
62.5%
(30.6–86.3)
31.9%
(22.3–43.4)
35%
(25.5–45.9)
0.803
(0.01–71.9)
1.026
(0.97–1.08)
0.782
(0.17–3.56)
Complex loculated effusion 7.4%
(2.9–17.6)
92.3%
(75.9–97.9)
66.7%
(30–90.3)
32.4%
(22.9–43.7)
35%
(25.5–45.9)
0.963
(0–1173)
1.003
(0.96–1.05)
0.96
(0.16–5.61)
Homogenous echogenic
effusion
5.6%
(1.9–15.1)
84.6%
(66.5–93.9)
42.9%
(15.8–74.9)
30.1%
(20.8–41.4)
31.3%
(22.2–42.1)
0.361
(0–39270)
1.116
(1.06–1.18)
0.324
(0.07–1.57)
Incapsulated effusion 1.9%
(0.3–9.8)
92.3%
(75.9–97.9)
33.3%
(6.1–79.2)
31.2%
(21.9–42.2)
31.3%
(22.2–42.1)
0.241
(0–?)
1.063
(1.02–1.11)
0.226
(0.02–2.62)
Total effusion 94.4%
(84.9–98.1)
11.5%
(4.0–29)
68.9%
(57.7–78.3)
50%
(18.8–81.)
67.5%
(56.6–76.8)
1.068
(0.98–1.17)
0.482
(0–138.6)
2.217
(0.42–11.8)
Non-specific US finding or
lesion undetectable by US
5.6%
(1.9–15.1)
88.5%
(71–96)
50%
(18.8–81.2)
31.1%
(21.7–42.3)
32.5%
(23.2–43.4)
0.482
(0–61640)
1.068
(1.02–1.12)
0.451
(0.08–2.41)
Tumor mass or node 1.9%
(0.3–9.8)
100%
(87.1–100)
100%
(20.7–100)
32.9%
(23.6–43.9)
33.8%
(24.4–44.6)
ND
0.982
(0.95–1.02)
ND
Calcification 5.6%
(1.9–15.1)
100%
(87.1–100)
100%
(43.9–100)
33.8%
(24.2–44.9)
36.3%
(26.6–47.2)
ND
0.944
(0.91–0.98)
ND
Atelectasis 1.9%
(0.3–9.8)
100%
(87.1–100)
100%
(20.7–100)
32.9%
(23.6–43.9)
33.8%
(24.4–44.6)
ND
0.982
(0.95–1.02)
ND
Penetration into
thoracic wall
0%
(0.0–6.6)
73.1%
(53.9–86.3)
0%
(0.0–35.4)
26.0%
(17.3–37.1)
23.8%
(15.8–34.1)
0.09
(0.01–1.32)
1.37
0.059
(0–0.42)
Legend: ND – non-defined, PPV – positive predictive value, NPV – negative predictive value, DA – diagnostic accuracy, +LR – likeli-
hood ratio for a positive test, –LR – likelihood ratio for a negative test, DO – diagnostic odds
TABLE 4
PRESENCE OF A SINGLE RADIOLOGIC SIGN ON US DEPENDING ON THE PATHOHISTOLOGIC DIAGNOSIS
Characteristic sign Total (N=80) Mesothelioma (N=54) Other diagnoses (N=26) p-value*
US-finding, number (%)
Anechogenic effusion
Complex non-loculated effusion
Complex loculated effusion
Homogenous echogenic effusion
Incapsulated effusion
Total effusion
Nonspecific US finding or lesion undetectable by US
Tumor mass or node
Calcification
Atelectasis
Penetration into thoracic wall
51 (63.8)
8 (10.0)
6 (7.5)
7 (8.8)
3 (3.8)
74 (92.5)
6 (7.5)
1 (1.3)
3 (3.8)
1 (1.3)
7 (8.8)
38 (70.4)
5 (9.3)
4 (7.4)
3 (5.6)
1 (1.9)
51 (94.4)
3 (5.6)
1 (1.9)
3 (5.6)
1 (1.9)
0
13 (50.0)
3 (11.5)
2 (7.7)
4 (15.4)
2 (7.7)
23 (88.5)
3 (11.5)
0
0
0
7 (26.9)
0.0759
0.7503
0.9639
0.1451
0.1978
0.3413
0.3413
0.4850
0.2206
0.4850
0.0001
*p-value for difference between diagnoses
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TABLE 6
DIAGNOSTIC CHARACTERISTICS OF COMBINED MODELS OF US EXAMINATIONS WITH 95% INTERVALS OF RELIABILITY
Model Sensitivity Specificity PPV NPV DA +LR –LR DO
Positive predictors 70.4%
(57.2–80.1)
50%
(32.1–67.9)
74.5%
(61.1–84.5)
44.8%
(28.4–62.5)
63.8%
(52.8–73.4)
1.407
(1.18–1.67)
0.593
(0.45–0.78)
2.375
(0.90–6.24)
Negative predictors 7.4%
(2.9–17.6)
65.4%
(46.2–80.6)
30.8%
(12.7–57.6)
25.4%
(16.5–36.9)
26.3%
(17.9–36.8)
0.214
(0–121.6)
1.416
(1.28–1.57)
0.151
(0.04–0.55)
Combined model 92.6%
(82.5–97.1)
23.8%
(11–42.1)
71.4%
(60–80.7)
60%
(31.3–83.2)
70%
(59.2–78.9)
1.204
(1.09–1.33)
0.321
(0.07–1.56)
3.75
(0.96–14.7)
Legend: ND – non-defined, PPV – positive predictive value, NPV – negative predictive value, DA – diagnostic accuracy, +LR – likeli-
hood ratio for a positive test, –LR – likelihood value for a negative test, DO – diagnostic odds
TABLE 7
PRESENCE OF A SINGLE RADIOLOGIC SIGN ON CT IMAGES DEPENDING ON THE PATHOHISTOLOGIC DIAGNOSIS
Characteristic finding Total (N=80) Mesothelioma (N=54) Other diagnoses (N=26) p-value*
CT-finding, number (%)
Effusion
Pleural thickening
Plaque
Calcification
Osteolysis
Tumors mass or node
Pneumothorax
Atelectasis
Inflammatory infiltrate
Scar lesions
76 (95.0)
44 (55.0)
11 (13.8)
6 (7.5)
0
14 (17.5)
4 (5.0)
5 (6.3)
6 (7.5)
1 (1.3)
52 (96.3)
36 (66.7)
11 (20.4)
6 (11.1)
0
6 (11.1)
0
4 (7.4)
1 (1.9)
0
24 (92.3)
8 (30.8)
0
0
0
8 (30.8)
4 (15.4)
1 (3.9)
5 (19.2)
1 (3.9)
0.4433
0.0025
0.0132
0.0772
0.9999
0.0302
0.0031
0.5377
0.0057
0.1470
*p-value for the difference between diagnoses
TABLE 8
DIAGNOSTIC VALUES OF CHARACTERISTIC CT FINDINGS WITH 95% INTERVALS OF RELIABILITY
Characteristic
finding
Sensitivity Specificity PPV NPV DA +LR –LR DO
Effusion 96.3%
(87.5–98.9)
7.7%
(2.1–24.1)
68.4%
(57.3–77.8)
50%
(15–85)
67.5%
(56.6–76.8)
1.043
(0.96–1.13)
0.482
(0–164200)
2.167
(0.29–16.3)
Pleural
thickening
66.7%
(53.4–77.8)
69.2%
(50–83.5)
81.8%
(68–90.5)
50%
(34.5–65.5)
67.5%
(56.6–76.8)
2.167
(1.65–2.85)
0.482
(0.41–0.56)
4.5
(1.64–12.3)
Plaque 20.4%
(11.8–32.9)
100%
(87.1–100)
100%
(74.1–100)
37.7%
(27.2–49.5)
46.3%
(35.8–57.1)
1.524
(1.22–1.9)
0.796
(0.76–0.83)
9.845
(1.25–290)
Calcification 11.1%
(5.2–22.2)
100%
(87.1–100)
100%
(61–100)
35.1%
(25.2–46.5)
40%
(30–51)
1.413
(1.07–1.87)
0.889
(0.85–0.93)
4.869
(0.55–151)
Tumor mass
or node
11.1%
(5.2–22.2)
69.2%
(50–83.5)
42.9%
(21.4–67.4)
27.3%
(18–39)
30%
(21.1–40.8)
0.361
(0.02–6.3)
1.284
(1.17–1.4)
0.281
(0.09–0.92)
Pneumothorax 0%
(0–6.6)
84.6%
(66.5–93.9)
0%
(0–49)
29%
(20–40)
27.5%
(18.9–38.1)
0
(ND)
1.182
(ND)
0
(ND)
Atelectasis 7.4%
(2.9–17.6)
96.2%
(81.1–99.3)
80%
(37.6–96.4)
33.3%
(23.7–44.6)
36.3%
(26.6–47.2)
1.926
(0–6250)
0.963
(0.92–1)
2
(0.21–18.9)
Inflammatory
infiltrate
1.9%
(0.3–9.8)
80.8%
(62.1–91.5)
16.7%
(3–56.4)
28.4%
(19.4–39.5)
27.5%
(18.9–38.1)
0.096
(0–?)
1.215
(1.15–1.29)
0.08
(0.01–0.72)
Scar lesions 0%
(0–6.6)
96.2%
(81.1–99.3)
0%
(0–79.4)
31.7%
(22.5–42.6)
31.3%
(22.2–42.1)
0
(ND)
1,04
(ND)
0
(ND)
Legend: ND – non-defined, PPV – positive predictive value, NPV – negative predictive value, DA – diagnostic accuracy, +LR – likeli-
hood ratio for a positive test, –LR – likelihood ratio for a negative test, DO – diagnostic odds
Computed tomography: has the highest sensitivity
94.4% with 35.5% specificity.
Direct digital radiography: has a sensitivity of 90.7%
and specificity 46.2%. The diagnostic accuracy of DDR in
relation to CT is 90%,when the two methods are com-
pared. The results indicate that DDR is a less sensitive
method in detecting primarily positive predictors.
Ultrasound: has a diagnostic accuracy of 80% in rela-
tion to CT. The results for US have revealed its markedly
low specificity of 23.8% for mesothelioma, with diagnos-
tic odds of 3.75 (95% CI, 0.96–14.7) that is without statis-
tical significance. However, the results for US, when
compared to the results for CT, are only slightly less sen-
sitive in detecting positive predictors, primarily because
of inferior contrast resolution (sensitivity 90.7%, speci-
ficity 46.2%, PPV 77.8%, NPV 70.6% for mesothelioma)
with diagnostic odds of 8.4.
This study demonstrated that all three methods are
mutually complementary in detecting particular radio-
logic signs of mesothelioma. No method among the stud-
ied ones yielded a pathognomonic radiologic sign for the
diagnosis of mesothelioma.
Comparision with literature data for average age
and sex
The comparison of the results obtained for the aver-
age age of examinees with a confirmed diagnosis of meso-
thelioma showed that they conform with data in the lite-
rature regarding the average age of patients with meso-
thelioma. According to data from the literature4,5, the av-
erage age of patients with mesothelioma is about 48,5±
16,1SD.The ratio of men and women with mesothelioma
in this study also corresponds to the data in the lite-
rature3,5.
Comparision with literature data for radiological
signs
Plaques: In the literature various ranges of sensitivity
for DDR in detecting plaques6 are stated, from 30% to
80%; in these data the proportion of false positive find-
ings is 20%, considerably improved by 18% with the addi-
tion of a lateral view radiogram6. The same authors spec-
ify negative DDR findings in as many as 20% of patients
with mesothelioma6. Atelectasis or parenchima consoli-
dation: contrary to data in the literature, as is stated in
some publications by Lynch and Benamore7,8, in this
study we didn’t confirm either atelectasis or parenchyma
consolidation as a negative predictor.
Effusions: Benamore, Odoherty and Entwisle8, as well
as Lichtenstein9–11, also found no characteristic US sign
pathognomonic for mesothelioma, which corresponds with
the results of this study. In their results homogenous
echogenic and incapsulated pleural effusions were also
found to be negative predictors for the diagnosis of meso-
thelioma, although with less statistical significance than
in the case of thoracic wall penetration, but with high
specificity.
Pleural thickening: according to Peacock12, the speci-
ficity of CT for pleural thickening, but also for nodes, is
94%, for mediastinal thickening it is 98%, and for circu-
lar thickening it is 100%. Scott and associates13 asserted
that a combination of CT and biopsy raises the sensitiv-
ity for differentiating malignant from benign pleural dis-
eases from 83% to 100%.
Pneumothorax: Pneumothorax is stated in the litera-
ture as a negative predictor for the diagnosis of meso-
thelioma14, but for the other negative predictors there
are no reliability data.
Remy-Jardin, Staples and Leung15 state 98 to 100%
sensitivity, and 87 to 92% specificity of CT in diagnosing
malignant pleural thickening. Remy-Jardin 15 accentu-
ates the higher sensitivity and specificity of multislice
CT.
According to the literature up to now16, CT is more
sensitive than other methods, particularly in the assess-
ment of plaque extent17, most probably due to better dif-
ferentiation of extrapleural fat and surrounding opaci-
ties. This method exhibits higher image sensitivity in
relation to DDR and US17, but it hasn’t the expected sig-
nificance that is generally presumed in clinical practice.
It has a distinctly higher sensitivity only in detecting
pleural thickening. In the works18 of Hierholzer, CT and
MR have comparable sensitivity in diagnosing malignant
mesothelioma.
More recent studies19,20 have shown a high sensitivity
of PET CT.
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TABLE 9
MODELS OF CT IMAGING WITH 95% INTERVALS OF RELIABILITY
Model Sensitivity Specificity PPV NPV DA +LR –LR DO
Positive
predictors
72.2%
(59.1–82.4)
69.2%
(50–83.5)
83%
(69.9–91.1)
54.6%
(38–70.2)
71.3%
(60.5–80)
2.347
(1.8–3.06)
0.401
(0.34–0.48)
5.85
(2.1–16.3)
Negative
predictors
13%
(6.4–24.4)
42.3%
(25.5–61.1)
31.8%
(16.4–52.7)
19%
(10.9–31)
22.5%
(14.7–32.8)
0.225
(0.03–1.68)
2.057
(1.55–2.74)
0.109
(0.04–0.33)
Combined
model
94.4%
(84.9–98.1)
38.5%
(22.4–57.5)
76.1%
(64.7–84.7)
76.9%
(49.7–91.8)
76.3%
(65.9–84.2)
1.535
(1.36–1.74)
0.144
(0.05–0.38)
10.63
(2.6–43.4)
Legend: ND – non-defined, PPV – positive predictive value, NPV – negative predictive value, DA – diagnostic accuracy, +LR – likeli-
hood of reliability for a positive test, –LR – likelihood of reliability for a negative test, DO – diagnostic odds
Pleurocentesis under us
In as many as 69 patients the final diagnosis was es-
tablished from material obtained under US supervision.
It must be stressed that an adequate sample was ob-
tained from all patients, in the sense that the quantity of
effusion was sufficient (>50 ccm) for microbiological,
biochemical and cytologic analysis. This result corre-
sponds with those from other authors21 who had a per-
centage of adequate samples in the range of 97–100%.
The percentage of negative pleurocenteses is stated21 as
10%, when it is not guided by US. It is particularly im-
portant to emphasize the importance of the non-invasive
feature of the ultrasonic method obtaining material for
PHD analysis, that does not use ionizing radiation.
The results have opened the question concerning the
need for a consensus about the use of particular methods
(having in view their diagnostic properties) in the detec-
tion, and notably in the follow up of these patients. The
multivariant models formed in this study indicate that
CT best satisfies the criteria for diagnosing mesotheli-
oma, when it is used as an independent method. CT is
also the best method for staging and preoperative evalua-
tion of tumor spread.
In the final analysis of this investigation, DDR exhibi-
ted statistical characteristics of the »first looking« me-
thod in diagnosing mesothelioma. The above mentioned
characteristics make it also the method of choice in the
follow up of patients with mesothelioma, According to
the results, US is a satisfactory follow up method for
monitoring the course of disease in these patients. For a
more accurate assessment of the stage of disease, judging
from these results it would be necessary to perform CT in
these patients.
Advantages of the CT and MR
Acoording to the literature5 CT usually provides pre-
cise localization and extent of the disease and may be of
value in assessing chest wall and mediastinal involv-
ment. In specific situations, magnetic resonance imaging
(MR) may be useful as problem-solving tool when CT
findings of the chest wall and diaphragmatic invasion are
equivocal. CT and MR imaging are of nearly equivalent
diagnostic accuracy in staging malignant pleural meso-
thelioma22. MR is superior to CT in revealing solitary foci
of chest wall invasion and endothoracic fascia involv-
ment and in showing diaphragmatic muscle invasion;
however, this advantage does not affect surgical tret-
mant. For cost reasons, CT should be considered the
standard diagnostic study before therapy22, although CT
and MR have comparable sensitivity in diagnosing me-
sothelioma18. Unfortunately, we did not have MR in our
Clinic, and surgeons still operate based on CT studies23.
Today, also CT-PET is indicated for diagnosis and staging
of malignant pleural mesothelioma in the selection of pa-
tients who might benefit from surgery after neoadjuvant
therapy. CT- PET is highly specific in identifying small
recurrences and/or remote methastases23.
Using spiral CT instead of widely accepted MDCT
technology may be potential drawback of this study. Ac-
cording to the literature MDCT of the chest is superior in
comparision with single-slice CT of the chest in detecting
some small size lesions24. Unfortunatly, we had only sin-
gle slice CT in our Clinic. But, also, in future maybe we
should think abouth the potential doses delivered by
newer CT tehnologies that can be quite higer25.
It was necessary to perform CT despite the fact that
the tumor had previously been proven by DDR and US
because of the disease staging process; the clinicians
could only decide on further therapy after the staging
process was completed.
Another disadvantage of this investigation was not
analyzing accuracy of each method based on different
features of the tumor (size, location). Statistical analysis
included only data on their number (Table 1, 4, 7). These
variations of the tumor were not analysed since the aim
has been to establish the presence of characteristic radio-
logic signs, in each diagnostic method. More important, it
was to determine whether a pathognomonic radiologic
sign for the diagnosis of mesothelioma exists.
However, the results listed in Tables 1, 4, and 7 indi-
cate the presence of 14 nodal lesions and tumor masses
on CT examination, 13 on DDR and only one on the US
exam. Obviously, the size of the lesion affects the sensi-
tivity24 of the method, as well as their location. We found
only one peripheral nodal lesions on US exam. After the
literature,9,10, use of the chest US is limited by the loca-
tion of the lesion. The difference between the methods is
probably lesser, since mesothelioma affects primary pe-
ripheral zone of the lungs (mostly pleura)8,10.
The choice of the algorithm at the first visit of such a
patient would be: DDR, US, CT.
For regular follow up DDR and US would be manda-
tory, while in case of progression of disease or new clini-
cal signs CT should be used24.
Conclusion
The results of this investigation indicate that CT best
satisfies the criteria for individually diagnosing mesothe-
lioma.
DDR demonstrated statistical characteristics of the
method of choice, at the first visit of the patient, and US
had a surprisingly high sensitivity. The methods emerged
as mutually complementary in the detection of radiologic
signs of mesothelioma.
None of the examinations that were used succeeded in
revealing a pathognomonic radiologic sign for the diag-
nosis of mesothelioma, which is of particular importance
in order to avoid the overestimation of newer methods
(CT) in diagnosing this disease. In view of its statistical
characteristics, CT is the method of choice for determin-
ing the stage of extent of mesothelioma.
Based on the results that are presented, the proposed
choice of algorhythm at the first visit of a patient with
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suspected mesothelioma would therefore be: DDR, US,
CT.
In the course of regular follow ups, DDR and US
should be used, and in case of progression or appear-
ance of new clinical signs, CT should be added. Each
imaging modality, even the latiest (PET-CT and MR)
has its advantages and limitations, but their combined
use is crucial in determining the most appropriate
treatment options in patients with malignant pleural
mesothelioma.
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MOGU]NOSTI I OGRANI^ENJA DIREKTNE DIGITALNE RADIOGRAFIJE, ULTRAZVUKA I
KOMPJUTORIZIRANE TOMOGRAFIJE U DIJAGNOSTICI MEZOTELIOMA PLEURE
S A @ E T A K
Cilj istra`ivanja je bio usporediti mogu}nosti i ograni~enja direktne digitalne radiografije prsi{ta (DDR), ultrazvuka
prsi{ta (UZV) i kompjutorizirane tomografije prsi{ta (CT) u otkrivanju mezotelioma pleure. Istra`ivanje je provedeno
tijekom godine dana, na 80 bolesnika, uzastopno upu}enih u specijaliziranu ustanovu, s klini~kom sumnjom na mezo-
teliom. Metoda istra`ivanja bila je usporedba nalaza dobivenih ispitivanim metodama sa patohistolo{kim nalazom biop-
sije za svakog bolesnika. Nalazi dobiveni navedenim metodama klasificirani su prema prona|enim radiolo{kim znaci-
ma, za svakog pacijenta posebno. Svakom od kori{tenih metoda analizirani su sljede}i radiolo{ki znakovi: pleuralni
izljev, zadebljanja pleure, plakovi,kalcifikati, tumorske mase ili nodusi, pneumotoraks, atelektaza, upalni infiltrate,
o`iljne lezije, elevacija o{ita i osteoliza. Dobiveni rezultati uspore|eni su s patohistolo{kim nalazom i obra|eni stan-
dardnim statisti~kim metodama. Najve}u osjetljivost pokazao je CT (94,4%). Slijedi UZV (92,6%), te DDR (90,7%).
Najve}a je specifi~nost DDR (46,2%), slijedi CT (35, 5%) i UZV (23, 8%). Usporedba metoda pokazala je 90% dijag-
nosti~ku to~nost DDR-e u odnosu na CT. UZV je pokazao to~nost od 80% u odnosu na CT. CT, kao pojedina~na metoda,
najbolje zadovoljava ve}inu kriterija za dijagnostiku mezotelioma. Nije na|en patognomoni~an radiolo{ki znak za dijag-
nozu mezotelioma.
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